Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients
- Conditions
- CT Scanning Patients
- Registration Number
- NCT02946450
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Brief Summary
The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
- subjects in need of CT scanning
- subjects who signed up informed consent
Exclusion Criteria
- Known allergy or hypersensitivity to the study medication, ingredient of the medication, and Iodine type medication
- severe renal insufficiency patients
- severe hypothyroidism
- severe local infection or bacteremia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method adverse events, adverse drug reaction, serious adverse events, serious drug reaction, laboratory data, vital signs 14 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Asan medical center
🇰🇷Seoul, Korea, Republic of